Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.03%-1.9M | -101.67%-4.72M | -249.43%-1.69M | 3,596.83%2.2M | 4,423.53%2.31M | 25.26%-1.22M | -437.66%-2.34M | 1,742.03%1.13M | 97.39%-63K | -67.92%51K |
| Net income from continuing operations | -53.76%-4.21M | 53.25%-900K | -340.88%-1.2M | -74.70%-1.31M | -41.92%-799K | 6.16%-2.74M | -375.31%-1.93M | 148.78%499K | 16.92%-751K | 4.25%-563K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -69.70%40K | --0 | --0 | ---- | ---- |
| Depreciation and amortization | 25.50%566K | -82.41%38K | -37.82%97K | 465.79%215K | 426.83%216K | 180.12%451K | 414.29%216K | 300.00%156K | -9.52%38K | 7.89%41K |
| Unrealized gains and losses of investment securities | 42.15%-210K | 104.90%21K | 276.67%113K | -1,174.29%-376K | 3,100.00%32K | -270.42%-363K | -427.48%-429K | 111.63%30K | -74.64%35K | -99.50%1K |
| Remuneration paid in stock | --69K | --0 | --0 | --0 | --69K | --0 | --0 | --0 | --0 | --0 |
| Deferred tax | 214.29%24K | -105.02%-44K | 105.40%48K | -4,750.00%-97K | 2,050.00%117K | -115.00%-21K | 793.88%876K | -855.91%-889K | -101.64%-2K | -146.15%-6K |
| Other non cashItems | 38.78%2.05M | 52.74%640K | 28.39%511K | 38.30%473K | 33.86%423K | 16.69%1.48M | 31.35%419K | 24.38%398K | 8.57%342K | 1.94%316K |
| Change In working capital | -203.28%-185K | -198.86%-4.47M | -234.19%-1.26M | 1,304.26%3.3M | 758.40%2.25M | 92.17%-61K | -394.69%-1.5M | 18.41%939K | 111.03%235K | 424.00%262K |
| -Change in receivables | -592.05%-1.65M | -251.28%-5.48M | -163.45%-946K | 1,830.82%3.07M | 617.33%1.7M | -182.99%-239K | -1,331.19%-1.56M | 4,709.68%1.49M | -55.21%159K | -3,090.91%-329K |
| -Change in prepaid assets | 225.28%1.74M | 4,675.00%1.53M | 213.33%51K | -393.75%-141K | -40.08%299K | 135.81%534K | -64.44%32K | -1,025.00%-45K | 104.87%48K | 184.43%499K |
| -Change in payables and accrued expense | 132.97%209K | 189.02%146K | 3.99%-505K | 613.95%307K | 1,907.69%261K | 68.09%-634K | 85.81%-164K | -226.71%-526K | 107.48%43K | 113.68%13K |
| -Change in other current assets | -684.47%-602K | -3,440.00%-668K | -21.05%15K | 526.67%64K | -116.46%-13K | -97.29%103K | -99.31%20K | -98.53%19K | 98.85%-15K | -91.38%79K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other working capital | -28.57%125K | --0 | ---- | ---- | ---- | 197.22%175K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.03%-1.9M | -101.67%-4.72M | -249.43%-1.69M | 3,596.83%2.2M | 4,423.53%2.31M | 25.26%-1.22M | -437.66%-2.34M | 1,742.03%1.13M | 97.39%-63K | -67.92%51K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 819.61%367K | 0 | 193.22%316K | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | --316K | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | --51K | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 819.61%367K | --0 | 193.22%316K | -95.93%51K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.14%2.63M | 114.94%5.71M | 472.32%2.99M | -395.54%-2.98M | -948.14%-3.09M | 228.89%2.57M | 886.39%2.66M | -176.55%-802K | 275.17%1.01M | 62.66%-295K |
| Net issuance payments of debt | 13.09%3.66M | 104.84%6.06M | 676.88%3.29M | -407.01%-2.85M | -3,843.06%-2.84M | 98.29%3.24M | 4,263.38%2.96M | -682.19%-571K | 1,387.50%927K | -103.89%-72K |
| Net common stock issuance | -48.86%179K | --0 | --0 | ---- | ---- | 0.00%350K | --0 | --0 | ---- | ---- |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | -19.41%-1.22M | -14.77%-342K | -33.33%-308K | -17.54%-315K | -13.45%-253K | -11.48%-1.02M | -11.61%-298K | -6.45%-231K | -10.29%-268K | -18.62%-223K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2.14%2.63M | 114.94%5.71M | 472.32%2.99M | -395.54%-2.98M | -948.14%-3.09M | 228.89%2.57M | 886.39%2.66M | -176.55%-802K | 275.17%1.01M | 62.66%-295K |
| Net cash flow | ||||||||||
| Beginning cash position | 340.87%2.22M | 2.52%1.95M | -47.69%658K | 450.57%1.44M | 340.87%2.22M | -87.95%504K | 118.23%1.9M | -19.92%1.26M | -92.05%261K | -87.95%504K |
| Current changes in cash | -57.92%723K | 212.58%994K | 99.85%1.29M | -178.13%-779K | -221.72%-785K | 146.74%1.72M | 186.18%318K | 192.69%647K | 157.40%997K | 72.02%-244K |
| Effect of exchange rate changes | --1K | 0.00%1K | --0 | --0 | --0 | --0 | 0.00%1K | -100.00%-2K | --0 | 103.70%1K |
| End cash Position | 32.58%2.95M | 32.58%2.95M | 2.52%1.95M | -47.69%658K | 450.57%1.44M | 340.87%2.22M | 340.87%2.22M | 118.23%1.9M | -19.92%1.26M | -92.05%261K |
| Free cash from | -56.03%-1.9M | -101.67%-4.72M | -249.43%-1.69M | 3,596.83%2.2M | 4,423.53%2.31M | 27.53%-1.22M | -437.66%-2.34M | 1,742.03%1.13M | 97.44%-63K | -67.92%51K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.